The Role of NPY and Ghrelin in Anorexia Nervosa

E-ISSN： 1873-4286|18|31|4766-4778

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.31, 2012-10, pp. : 4766-4778

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The human genetics of anorexia nervosa

By Gorwood P. Kipman A. Foulon C.

European Journal of Pharmacology, Vol. 480, Iss. 1, 2003-11 ,pp. : 163-170

Elsevier

Access to resources Recommend Favorite

Management of Psychiatric Comorbidity in Anorexia Nervosa and Bulimia Nervosa

By Woodside Blake D. Staab Randolf

CNS Drugs, Vol. 20, Iss. 8, 2006-01 ,pp. : 655-663

Adis International

Access to resources Recommend Favorite

Gastrointestinal Disturbances in Anorexia Nervosa and Bulimia Nervosa

Current Drug Targets-CNS & Neurological Disorders, Vol. 2, Iss. 1, 2003-02 ,pp. : 1-9

Bentham Science Publishers

Access to resources Recommend Favorite

New targets in the treatment of anorexia nervosa

By Roerig James L Mitchell James Steffen Kristine J

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 1, 2005-02 ,pp. : 135-151

Informa Healthcare

Access to resources Recommend Favorite

Available pharmacological treatments for anorexia nervosa

By Powers Pauline S Santana Carlos

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 11, 2004-11 ,pp. : 2287-2292

Informa Healthcare

Access to resources Recommend Favorite